«B-Lymphocytes

Below is an extended B-Lymphocytes patents listing. Click here to return to the B-Lymphocytes main in depth entry.

Patents :
US Patent No.	Title
7393632	Use of multiple recombination sites with unique specificity in recombinational cloning
7407662	Modified viral particles with immunogenic properties and reduced lipid content
7407663	Modified immunodeficiency virus particles
7408029	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7408031	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7408041	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
7410642	Assays and therapies for latent viral infection
7410773	Method of preparing an undifferentiated cell
7410795	Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
7411051	Antibodies to HDPPA04 polypeptide
7413733	Antigen transduced T cells used as a delivery system for antigens
7405302	5-lipoxygenase-activating protein (FLAP) inhibitors
7405286	Stars--A muscle-specific actin-binding protein
7405285	Immunostimulatory oligonucleotide multimers
7393684	Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
7393859	Amide substituted imidazoquinolines
7393940	Screening methods and sequences relating thereto
7394210	System and method for controlling luminaires
7396827	Pharmaceutical compositions and treatment methods
7396904	Tumor-associated peptides binding to MHC-molecules
7402322	Methods of treatment for septic shock with urine extract
7402730	Knockout animals manifesting hyperlipidemia
7405038	Stable cell lines resistant to apoptosis and nutrient stress and methods of making same
7405047	Method for estimation of the amount of specific cell types
7413736	Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
7413868	Use of particulate labels in bioanalyte detection methods
7425607	Compositions comprising a lung tumor antigen
7425611	Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7427405	Immunostimulatory oligonucleotide multimers
7427495	Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases
7427665	Chronic lymphocytic leukemia cell line
7429467	Emulsion compositions
7429486	Recombinant production of mixtures of antibodies
7429487	Fusion partner for production of monoclonal rabbit antibodies
7425541	Enzyme-cleavable prodrug compounds
7425329	Methods for treating bone cancer pain by administering a nerve growth factor antagonist
7423042	Compounds
7414121	Chimeric, human and humanized anti-CSAp monoclonal antibodies
7414170	Transgenic bovines capable of human antibody production
7416730	Derivatives of the IL-2 receptor gamma chain, their production and use
7419792	Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
7419811	Use of specifically engineered enzymes to enhance the efficacy of prodrugs
7420033	Composition of lactoferrin related peptides and uses thereof
7420039	Individualized anti-cancer antibodies
7420099	Transgenic animals and uses thereof
7422739	Anti-CD20 antibodies
7422751	Epstein-barr-virus-specific immunization
7429690	Transgenic bovines having reduced prion protein production

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.